Association of lenvatinib plasma concentration with clinical efficacy and adverse events in patients with hepatocellular carcinoma
ConclusionMaintaining Ctrough median above 42.68 ng/mL was crucial for achieving the ORR in patients with HCC.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Anorexia | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Drugs & Pharmacology | Eating Disorders & Weight Management | Hepatocellular Carcinoma | Hypertension | Liver Cancer | Study